Trial
NCT01734941
TSO in Pediatric Autistic Spectrum Disorders
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Hadassah Medical Organization
Collaborators
—
Condition
Autistic Spectrum Disorders
Intervention
TSO
Why stopped
Well tolerated but failed to demonstrate significant activity. So it did not meet its primary endpoint or key secondary endpoints.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-02